10 Points to Consider when Evaluating your PsA Patients

July 13, 2016
Rheumatology Network Staff

Some new and old concepts to consider when evaluating patients with severe psoriatic arthritis (PsA) for cardiovascular diseases.

A study published in the April 25 issue of Arthritis Care and Research, shows that patients with PsA have a 55% increase in the risk of incident cardiovascular events. The overall risk of cardiovascular disease is 43% greater than that of the general population. By comparison, PsA patients face a 31% increased risk of congestive heart failure, 38% increased risk of incident cerebrovascular events and 57% increased risk of developing myocardial infarction. “Risk of Cardiovascular Morbidity in Patients with Psoriatic Arthritis: A Meta-Analysis of Observational Studies.” Ari Polachek, M.D., Zahi Touma, M.D., Ph.D., et. al. Arthritis Care and Research. April 25, 2016. DOI: 10.1002/acr.22926.